TD Asset Management »

4d Molecular Therapeutics In shares owned by TD Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $685k 52k 13.30
2021-03-31 $1.2M 27k 43.39
2020-12-31 $1.1M 27k 41.46

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Cibc Cad (CM)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Enbridge (ENB)
Amazon (AMZN)
Manulife Finl Corp (MFC)
Canadian Pacific Kansas City (CP)
Johnson & Johnson (JNJ)

View all positions for TD Asset Management

Top funds holding 4d Molecular Therapeutics In

Jupiter Topco
Henderson Group
RA Capital Management
BlackRock
Goldman Sachs Group
Novo A/S
BVF
State Street Corporation
Adage Capital Partners GP
Trails Edge Capital Partners
Vanguard Capital Management
Armistice Capital
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In